RNVU1-19

Across TCGA pan-cancer cohorts, RNVU1-19 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of RNVU1-19’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RNVU1-19 RNA is repressed in tumor relative to normal tissue. In most cancer types RNVU1-19 is over-expressed in tumor, although a few such as THCA and HNSC show the opposite, repressed pattern.

THCA, HNSC, and KIRC are the cancer types where RNVU1-19 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNVU1-19 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−1.634	<.001	8	view →
HNSC	Female	All	−0.664	.007	6	view →
KIRC	All	All	+0.248	<.001	6	view →
READ	Male	All	−0.410	.001	4	view →
KICH	All	All	−0.362	.002	4	view →
PRAD	All	All	+0.665	<.001	2	view →
LUAD	Male	All	+0.521	.040	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

RNVU1-19–THCA

Open the THCA breakdown →